{"transactions":[{"id":4639253,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18476,"kind":"person","name":"Blum Robert I","position":1,"cik":"0001288859","reported_name":"Blum Robert I","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2026-10-13T20:00:58.000Z","date":"2026-10-12","kind":"exercise","planned":true,"acquired":false,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":141745,"derivative":{"exercise_price":10.6,"exercise_date":"2017-03-28","expiration_date":"2027-02-28","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001061983-26-000099","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1288859/000106198326000099/form4.xml","form_type":"4"}},{"id":4639252,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18476,"kind":"person","name":"Blum Robert I","position":1,"cik":"0001288859","reported_name":"Blum Robert I","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2026-10-13T20:00:58.000Z","date":"2026-10-12","kind":"sale","planned":true,"acquired":false,"shares":7500,"price":62.88,"value":471600.0,"ownership":{"direct":true},"balance_after":278544,"source":{"system":"sec-edgar","filing":"0001061983-26-000099","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1288859/000106198326000099/form4.xml","form_type":"4"}},{"id":4639251,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18476,"kind":"person","name":"Blum Robert I","position":1,"cik":"0001288859","reported_name":"Blum Robert I","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2026-10-13T20:00:58.000Z","date":"2026-10-12","kind":"exercise","planned":true,"acquired":true,"shares":7500,"price":10.6,"value":79500.0,"ownership":{"direct":true},"balance_after":286044,"source":{"system":"sec-edgar","filing":"0001061983-26-000099","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1288859/000106198326000099/form4.xml","form_type":"4"}},{"id":4636134,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":22443,"kind":"person","name":"Malik Fady Ibraham","position":1,"cik":"0001551778","reported_name":"Malik Fady Ibraham","relationship":{"officer":true,"officer_title":"EVP Research & Development"}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2026-10-06T20:25:37.000Z","date":"2026-10-06","kind":"exercise","planned":true,"acquired":false,"shares":3500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":19886,"derivative":{"exercise_price":7.8,"exercise_date":"2018-03-27","expiration_date":"2028-02-27","underlying":"Common Stock","underlying_shares":3500},"source":{"system":"sec-edgar","filing":"0001061983-26-000098","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1551778/000106198326000098/form4.xml","form_type":"4"}},{"id":4636133,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":22443,"kind":"person","name":"Malik Fady Ibraham","position":1,"cik":"0001551778","reported_name":"Malik Fady Ibraham","relationship":{"officer":true,"officer_title":"EVP Research & Development"}}],"security":"Common Stock","published_at":"2026-10-06T20:25:37.000Z","date":"2026-10-06","kind":"sale","planned":true,"acquired":false,"shares":3500,"price":61.38,"value":214830.0,"ownership":{"direct":true},"balance_after":153902,"source":{"system":"sec-edgar","filing":"0001061983-26-000098","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1551778/000106198326000098/form4.xml","form_type":"4"}},{"id":4636132,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":22443,"kind":"person","name":"Malik Fady Ibraham","position":1,"cik":"0001551778","reported_name":"Malik Fady Ibraham","relationship":{"officer":true,"officer_title":"EVP Research & Development"}}],"security":"Common Stock","published_at":"2026-10-06T20:25:37.000Z","date":"2026-10-06","kind":"exercise","planned":true,"acquired":true,"shares":3500,"price":7.8,"value":27300.0,"ownership":{"direct":true},"balance_after":157402,"source":{"system":"sec-edgar","filing":"0001061983-26-000098","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551778/000106198326000098/form4.xml","form_type":"4"}},{"id":4627744,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18476,"kind":"person","name":"Blum Robert I","position":1,"cik":"0001288859","reported_name":"Blum Robert I","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2026-09-28T20:54:52.000Z","date":"2026-09-28","kind":"exercise","planned":true,"acquired":false,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":149245,"derivative":{"exercise_price":10.6,"exercise_date":"2017-03-28","expiration_date":"2027-02-28","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001061983-26-000097","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1288859/000106198326000097/form4.xml","form_type":"4"}},{"id":4627743,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18476,"kind":"person","name":"Blum Robert I","position":1,"cik":"0001288859","reported_name":"Blum Robert I","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2026-09-28T20:54:52.000Z","date":"2026-09-28","kind":"sale","planned":true,"acquired":false,"shares":7500,"price":65.46,"value":490950.0,"ownership":{"direct":true},"balance_after":278544,"source":{"system":"sec-edgar","filing":"0001061983-26-000097","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1288859/000106198326000097/form4.xml","form_type":"4"}},{"id":4627742,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18476,"kind":"person","name":"Blum Robert I","position":1,"cik":"0001288859","reported_name":"Blum Robert I","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2026-09-28T20:54:52.000Z","date":"2026-09-28","kind":"exercise","planned":true,"acquired":true,"shares":7500,"price":10.6,"value":79500.0,"ownership":{"direct":true},"balance_after":286044,"source":{"system":"sec-edgar","filing":"0001061983-26-000097","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1288859/000106198326000097/form4.xml","form_type":"4"}},{"id":4624935,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":22443,"kind":"person","name":"Malik Fady Ibraham","position":1,"cik":"0001551778","reported_name":"Malik Fady Ibraham","relationship":{"officer":true,"officer_title":"EVP Research & Development"}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2026-09-22T22:14:32.000Z","date":"2026-09-22","kind":"exercise","planned":true,"acquired":false,"shares":3500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":23386,"derivative":{"exercise_price":7.8,"exercise_date":"2018-03-27","expiration_date":"2028-02-27","underlying":"Common Stock","underlying_shares":3500},"source":{"system":"sec-edgar","filing":"0001061983-26-000096","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1551778/000106198326000096/form4.xml","form_type":"4"}},{"id":4624934,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":22443,"kind":"person","name":"Malik Fady Ibraham","position":1,"cik":"0001551778","reported_name":"Malik Fady Ibraham","relationship":{"officer":true,"officer_title":"EVP Research & Development"}}],"security":"Common Stock","published_at":"2026-09-22T22:14:32.000Z","date":"2026-09-22","kind":"sale","planned":true,"acquired":false,"shares":3500,"price":68.29,"value":239015.0,"ownership":{"direct":true},"balance_after":153902,"source":{"system":"sec-edgar","filing":"0001061983-26-000096","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1551778/000106198326000096/form4.xml","form_type":"4"}},{"id":4624933,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":22443,"kind":"person","name":"Malik Fady Ibraham","position":1,"cik":"0001551778","reported_name":"Malik Fady Ibraham","relationship":{"officer":true,"officer_title":"EVP Research & Development"}}],"security":"Common Stock","published_at":"2026-09-22T22:14:32.000Z","date":"2026-09-22","kind":"exercise","planned":true,"acquired":true,"shares":3500,"price":7.8,"value":27300.0,"ownership":{"direct":true},"balance_after":157402,"source":{"system":"sec-edgar","filing":"0001061983-26-000096","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551778/000106198326000096/form4.xml","form_type":"4"}},{"id":4618474,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":43928,"kind":"person","name":"Landry Robert E","position":1,"cik":"0001585160","reported_name":"Landry Robert E","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-09-15T21:23:13.000Z","date":"2026-09-15","kind":"sale","planned":true,"acquired":false,"shares":1000,"price":72.13,"value":72130.0,"ownership":{"direct":true},"balance_after":8184,"source":{"system":"sec-edgar","filing":"0001061983-26-000095","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1585160/000106198326000095/form4.xml","form_type":"4"}},{"id":4618470,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18476,"kind":"person","name":"Blum Robert I","position":1,"cik":"0001288859","reported_name":"Blum Robert I","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2026-09-15T21:20:38.000Z","date":"2026-09-14","kind":"exercise","planned":true,"acquired":false,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F9","text":"Exercise of stock options. Transaction is pursuant to a trading plan adopted by the reporting person intended to satisfy the conditions of Rule 10b5-1(c)."}],"balance_after":156745,"derivative":{"exercise_price":10.6,"exercise_date":"2017-03-28","expiration_date":"2027-02-28","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001061983-26-000094","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1288859/000106198326000094/form4.xml","form_type":"4"}},{"id":4618469,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18476,"kind":"person","name":"Blum Robert I","position":1,"cik":"0001288859","reported_name":"Blum Robert I","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2026-09-15T21:20:38.000Z","date":"2026-09-15","kind":"sale","planned":true,"acquired":false,"shares":97926,"price":69.33,"value":6789209.58,"ownership":{"direct":false,"nature":"by Trust 3. Beneficial Ownership Disclaimed."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"Sale of shares of common stock by The Bridget Blum 2026 Irrevocable Trust, of which reporting person is a co-trustee. Reporting person disclaims any beneficial ownership interest in the shares sold or the proceeds thereof."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001061983-26-000094","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1288859/000106198326000094/form4.xml","form_type":"4"}},{"id":4618468,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18476,"kind":"person","name":"Blum Robert I","position":1,"cik":"0001288859","reported_name":"Blum Robert I","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2026-09-15T21:20:38.000Z","date":"2026-09-14","kind":"gift","planned":true,"acquired":true,"shares":97926,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"by Trust 3. Beneficial Ownership Disclaimed."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Acquisition of shares by The Bridget Blum 2026 Irrevocable Trust, of which reporting person is a co-trustee. Reporting person disclaims any beneficial ownership interest in the shares held by the aforementioned trust."}],"balance_after":97926,"source":{"system":"sec-edgar","filing":"0001061983-26-000094","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1288859/000106198326000094/form4.xml","form_type":"4"}},{"id":4618467,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18476,"kind":"person","name":"Blum Robert I","position":1,"cik":"0001288859","reported_name":"Blum Robert I","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2026-09-15T21:20:38.000Z","date":"2026-09-14","kind":"gift","planned":true,"acquired":false,"shares":97926,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Transfer of shares of common stock to The Bridget Blum 2026 Irrevocable Trust, of which reporting person is a co-trustee. Reporting person disclaims any beneficial ownership interest in the shares held by the aforementioned trust upon completion of the gift transfer."}],"balance_after":278544,"source":{"system":"sec-edgar","filing":"0001061983-26-000094","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1288859/000106198326000094/form4.xml","form_type":"4"}},{"id":4618466,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18476,"kind":"person","name":"Blum Robert I","position":1,"cik":"0001288859","reported_name":"Blum Robert I","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2026-09-15T21:20:38.000Z","date":"2026-09-14","kind":"gift","planned":true,"acquired":false,"shares":1350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Charitable gift."}],"balance_after":376470,"source":{"system":"sec-edgar","filing":"0001061983-26-000094","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1288859/000106198326000094/form4.xml","form_type":"4"}},{"id":4618465,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18476,"kind":"person","name":"Blum Robert I","position":1,"cik":"0001288859","reported_name":"Blum Robert I","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2026-09-15T21:20:38.000Z","date":"2026-09-14","kind":"sale","planned":true,"acquired":false,"shares":7500,"price":73.44,"value":550800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Sale of shares of common stock acquired upon exercise of stock options. Transaction is pursuant to a trading plan adopted by the reporting person intended to satisfy the conditions of Rule 10b5-1(c)."}],"balance_after":377820,"source":{"system":"sec-edgar","filing":"0001061983-26-000094","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1288859/000106198326000094/form4.xml","form_type":"4"}},{"id":4618464,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18476,"kind":"person","name":"Blum Robert I","position":1,"cik":"0001288859","reported_name":"Blum Robert I","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2026-09-15T21:20:38.000Z","date":"2026-09-14","kind":"exercise","planned":true,"acquired":true,"shares":7500,"price":10.6,"value":79500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Acquisition of shares of common stock upon exercise of stock options. Transaction is pursuant to a trading plan adopted by the reporting person intended to satisfy the conditions of Rule 10b5-1(c)."}],"balance_after":385320,"source":{"system":"sec-edgar","filing":"0001061983-26-000094","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1288859/000106198326000094/form4.xml","form_type":"4"}},{"id":4616469,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":43928,"kind":"person","name":"Landry Robert E","position":1,"cik":"0001585160","reported_name":"Landry Robert E","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-09-11T23:12:26.000Z","date":"2026-09-11","kind":"sale","planned":true,"acquired":false,"shares":1000,"price":74.66,"value":74660.0,"ownership":{"direct":true},"balance_after":9184,"source":{"system":"sec-edgar","filing":"0001061983-26-000093","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1585160/000106198326000093/form4.xml","form_type":"4"}},{"id":3529098,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":22443,"kind":"person","name":"Malik Fady Ibraham","position":1,"cik":"0001551778","reported_name":"Malik Fady Ibraham","relationship":{"officer":true,"officer_title":"EVP Research & Development"}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2026-09-08T20:38:49.000Z","date":"2026-09-08","kind":"exercise","planned":true,"acquired":false,"shares":3500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":26886,"derivative":{"exercise_price":7.8,"exercise_date":"2018-03-27","expiration_date":"2028-02-27","underlying":"Common Stock","underlying_shares":3500},"source":{"system":"sec-edgar","filing":"0001061983-26-000092","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1551778/000106198326000092/form4.xml","form_type":"4"}},{"id":3529097,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":22443,"kind":"person","name":"Malik Fady Ibraham","position":1,"cik":"0001551778","reported_name":"Malik Fady Ibraham","relationship":{"officer":true,"officer_title":"EVP Research & Development"}}],"security":"Common Stock","published_at":"2026-09-08T20:38:49.000Z","date":"2026-09-08","kind":"sale","planned":true,"acquired":false,"shares":3500,"price":75.46,"value":264110.0,"ownership":{"direct":true},"balance_after":153902,"source":{"system":"sec-edgar","filing":"0001061983-26-000092","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1551778/000106198326000092/form4.xml","form_type":"4"}},{"id":3529096,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":22443,"kind":"person","name":"Malik Fady Ibraham","position":1,"cik":"0001551778","reported_name":"Malik Fady Ibraham","relationship":{"officer":true,"officer_title":"EVP Research & Development"}}],"security":"Common Stock","published_at":"2026-09-08T20:38:49.000Z","date":"2026-09-08","kind":"exercise","planned":true,"acquired":true,"shares":3500,"price":7.8,"value":27300.0,"ownership":{"direct":true},"balance_after":157402,"source":{"system":"sec-edgar","filing":"0001061983-26-000092","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551778/000106198326000092/form4.xml","form_type":"4"}},{"id":671514,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18114,"kind":"person","name":"PARSHALL B LYNNE","position":1,"cik":"0001073385","reported_name":"PARSHALL B LYNNE","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-09-01T20:51:57.000Z","date":"2026-09-01","kind":"sale","planned":true,"acquired":false,"shares":5000,"price":71.48,"value":357400.0,"ownership":{"direct":true},"balance_after":10784,"source":{"system":"sec-edgar","filing":"0001061983-26-000091","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1073385/000106198326000091/form4.xml","form_type":"4"}},{"id":672243,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18477,"kind":"person","name":"Callos Andrew","position":1,"cik":"0001852129","reported_name":"Callos Andrew","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2026-08-31T20:57:34.000Z","date":"2026-08-31","kind":"exercise","planned":true,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock options will vest over 4 years from the date of the grant, with 1/4th of the shares underlying the reporting person's option vesting on the one-year anniversary of the grant date and the remaining shares thereafter vesting monthly at a rate of 1/48th of the shares underlying the reporting person's option over the subsequent 36 months, subject to the reporting person's continued employment with the Issuer."}],"balance_after":0,"derivative":{"exercise_price":23.26,"exercise_date":"2022-03-31","expiration_date":"2031-03-31","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001061983-26-000090","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198326000090/form4.xml","form_type":"4"}},{"id":672242,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18477,"kind":"person","name":"Callos Andrew","position":1,"cik":"0001852129","reported_name":"Callos Andrew","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-08-31T20:57:34.000Z","date":"2026-08-31","kind":"sale","planned":true,"acquired":false,"shares":10000,"price":70.24,"value":702400.0,"ownership":{"direct":true},"balance_after":58555,"source":{"system":"sec-edgar","filing":"0001061983-26-000090","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198326000090/form4.xml","form_type":"4"}},{"id":672241,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18477,"kind":"person","name":"Callos Andrew","position":1,"cik":"0001852129","reported_name":"Callos Andrew","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-08-31T20:57:34.000Z","date":"2026-08-31","kind":"exercise","planned":true,"acquired":true,"shares":10000,"price":23.26,"value":232600.0,"ownership":{"direct":true},"balance_after":68555,"source":{"system":"sec-edgar","filing":"0001061983-26-000090","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198326000090/form4.xml","form_type":"4"}},{"id":672240,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18476,"kind":"person","name":"Blum Robert I","position":1,"cik":"0001288859","reported_name":"Blum Robert I","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2026-08-31T20:55:12.000Z","date":"2026-08-31","kind":"exercise","planned":true,"acquired":false,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":164245,"derivative":{"exercise_price":10.6,"exercise_date":"2017-03-28","expiration_date":"2027-02-28","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001061983-26-000089","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198326000089/form4.xml","form_type":"4"}},{"id":672239,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18476,"kind":"person","name":"Blum Robert I","position":1,"cik":"0001288859","reported_name":"Blum Robert I","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2026-08-31T20:55:12.000Z","date":"2026-08-31","kind":"sale","planned":true,"acquired":false,"shares":7500,"price":70.24,"value":526800.0,"ownership":{"direct":true},"balance_after":377820,"source":{"system":"sec-edgar","filing":"0001061983-26-000089","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198326000089/form4.xml","form_type":"4"}},{"id":672238,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18476,"kind":"person","name":"Blum Robert I","position":1,"cik":"0001288859","reported_name":"Blum Robert I","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2026-08-31T20:55:12.000Z","date":"2026-08-31","kind":"exercise","planned":true,"acquired":true,"shares":7500,"price":10.6,"value":79500.0,"ownership":{"direct":true},"balance_after":385320,"source":{"system":"sec-edgar","filing":"0001061983-26-000089","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198326000089/form4.xml","form_type":"4"}},{"id":684196,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":22443,"kind":"person","name":"Malik Fady Ibraham","position":1,"cik":"0001551778","reported_name":"Malik Fady Ibraham","relationship":{"officer":true,"officer_title":"EVP Research & Development"}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2026-08-18T20:38:26.000Z","date":"2026-08-18","kind":"exercise","planned":true,"acquired":false,"shares":3500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":30386,"derivative":{"exercise_price":7.8,"exercise_date":"2018-03-27","expiration_date":"2028-02-27","underlying":"Common Stock","underlying_shares":3500},"source":{"system":"sec-edgar","filing":"0001061983-26-000088","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198326000088/form4.xml","form_type":"4"}},{"id":684195,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":22443,"kind":"person","name":"Malik Fady Ibraham","position":1,"cik":"0001551778","reported_name":"Malik Fady Ibraham","relationship":{"officer":true,"officer_title":"EVP Research & Development"}}],"security":"Common Stock","published_at":"2026-08-18T20:38:26.000Z","date":"2026-08-18","kind":"sale","planned":true,"acquired":false,"shares":3500,"price":75.82,"value":265370.0,"ownership":{"direct":true},"balance_after":153902,"source":{"system":"sec-edgar","filing":"0001061983-26-000088","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198326000088/form4.xml","form_type":"4"}},{"id":684194,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":22443,"kind":"person","name":"Malik Fady Ibraham","position":1,"cik":"0001551778","reported_name":"Malik Fady Ibraham","relationship":{"officer":true,"officer_title":"EVP Research & Development"}}],"security":"Common Stock","published_at":"2026-08-18T20:38:26.000Z","date":"2026-08-18","kind":"exercise","planned":true,"acquired":true,"shares":3500,"price":7.8,"value":27300.0,"ownership":{"direct":true},"balance_after":157402,"source":{"system":"sec-edgar","filing":"0001061983-26-000088","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198326000088/form4.xml","form_type":"4"}},{"id":692267,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18476,"kind":"person","name":"Blum Robert I","position":1,"cik":"0001288859","reported_name":"Blum Robert I","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2026-08-10T21:11:48.000Z","date":"2026-08-10","kind":"exercise","planned":true,"acquired":false,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":171745,"derivative":{"exercise_price":10.6,"exercise_date":"2017-03-28","expiration_date":"2027-02-28","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001061983-26-000087","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198326000087/form4.xml","form_type":"4"}},{"id":692266,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18476,"kind":"person","name":"Blum Robert I","position":1,"cik":"0001288859","reported_name":"Blum Robert I","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2026-08-10T21:11:48.000Z","date":"2026-08-10","kind":"sale","planned":true,"acquired":false,"shares":7500,"price":76.76,"value":575700.0,"ownership":{"direct":true},"balance_after":377820,"source":{"system":"sec-edgar","filing":"0001061983-26-000087","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198326000087/form4.xml","form_type":"4"}},{"id":692265,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18476,"kind":"person","name":"Blum Robert I","position":1,"cik":"0001288859","reported_name":"Blum Robert I","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2026-08-10T21:11:48.000Z","date":"2026-08-10","kind":"exercise","planned":true,"acquired":true,"shares":7500,"price":10.6,"value":79500.0,"ownership":{"direct":true},"balance_after":385320,"source":{"system":"sec-edgar","filing":"0001061983-26-000087","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198326000087/form4.xml","form_type":"4"}},{"id":700887,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18477,"kind":"person","name":"Callos Andrew","position":1,"cik":"0001852129","reported_name":"Callos Andrew","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2026-07-30T20:26:19.000Z","date":"2026-07-30","kind":"exercise","planned":true,"acquired":false,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock options will vest over 4 years from the date of the grant, with 1/4th of the shares underlying the reporting person's option vesting on the one-year anniversary of the grant date and the remaining shares thereafter vesting monthly at a rate of 1/48th of the shares underlying the reporting person's option over the subsequent 36 months, subject to the reporting person's continued employment with the Issuer."}],"balance_after":10000,"derivative":{"exercise_price":23.26,"exercise_date":"2022-03-31","expiration_date":"2031-03-31","underlying":"Common Stock","underlying_shares":14000},"source":{"system":"sec-edgar","filing":"0001061983-26-000086","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198326000086/form4.xml","form_type":"4"}},{"id":700886,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18477,"kind":"person","name":"Callos Andrew","position":1,"cik":"0001852129","reported_name":"Callos Andrew","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-07-30T20:26:19.000Z","date":"2026-07-30","kind":"sale","planned":true,"acquired":false,"shares":14000,"price":79.88,"value":1118320.0,"ownership":{"direct":true},"balance_after":58555,"source":{"system":"sec-edgar","filing":"0001061983-26-000086","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198326000086/form4.xml","form_type":"4"}},{"id":700885,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18477,"kind":"person","name":"Callos Andrew","position":1,"cik":"0001852129","reported_name":"Callos Andrew","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-07-30T20:26:19.000Z","date":"2026-07-30","kind":"exercise","planned":true,"acquired":true,"shares":14000,"price":23.26,"value":325640.0,"ownership":{"direct":true},"balance_after":72555,"source":{"system":"sec-edgar","filing":"0001061983-26-000086","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198326000086/form4.xml","form_type":"4"}},{"id":703115,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18476,"kind":"person","name":"Blum Robert I","position":1,"cik":"0001288859","reported_name":"Blum Robert I","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2026-07-27T20:33:44.000Z","date":"2026-07-27","kind":"exercise","planned":true,"acquired":false,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":179245,"derivative":{"exercise_price":10.6,"exercise_date":"2017-03-28","expiration_date":"2027-02-28","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001061983-26-000085","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198326000085/form4.xml","form_type":"4"}},{"id":703114,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18476,"kind":"person","name":"Blum Robert I","position":1,"cik":"0001288859","reported_name":"Blum Robert I","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2026-07-27T20:33:44.000Z","date":"2026-07-27","kind":"sale","planned":true,"acquired":false,"shares":7500,"price":80.87,"value":606525.0,"ownership":{"direct":true},"balance_after":377820,"source":{"system":"sec-edgar","filing":"0001061983-26-000085","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198326000085/form4.xml","form_type":"4"}},{"id":703113,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18476,"kind":"person","name":"Blum Robert I","position":1,"cik":"0001288859","reported_name":"Blum Robert I","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2026-07-27T20:33:44.000Z","date":"2026-07-27","kind":"exercise","planned":true,"acquired":true,"shares":7500,"price":10.6,"value":79500.0,"ownership":{"direct":true},"balance_after":385320,"source":{"system":"sec-edgar","filing":"0001061983-26-000085","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198326000085/form4.xml","form_type":"4"}},{"id":704193,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":22443,"kind":"person","name":"Malik Fady Ibraham","position":1,"cik":"0001551778","reported_name":"Malik Fady Ibraham","relationship":{"officer":true,"officer_title":"EVP Research & Development"}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2026-07-23T20:09:01.000Z","date":"2026-07-21","kind":"exercise","planned":true,"acquired":false,"shares":3500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":33886,"derivative":{"exercise_price":7.8,"exercise_date":"2018-03-27","expiration_date":"2028-02-27","underlying":"Common Stock","underlying_shares":3500},"source":{"system":"sec-edgar","filing":"0001061983-26-000084","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198326000084/form4.xml","form_type":"4"}},{"id":704192,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":22443,"kind":"person","name":"Malik Fady Ibraham","position":1,"cik":"0001551778","reported_name":"Malik Fady Ibraham","relationship":{"officer":true,"officer_title":"EVP Research & Development"}}],"security":"Common Stock","published_at":"2026-07-23T20:09:01.000Z","date":"2026-07-21","kind":"sale","planned":true,"acquired":false,"shares":3500,"price":80.59,"value":282065.0,"ownership":{"direct":true},"balance_after":153902,"source":{"system":"sec-edgar","filing":"0001061983-26-000084","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198326000084/form4.xml","form_type":"4"}},{"id":704191,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":22443,"kind":"person","name":"Malik Fady Ibraham","position":1,"cik":"0001551778","reported_name":"Malik Fady Ibraham","relationship":{"officer":true,"officer_title":"EVP Research & Development"}}],"security":"Common Stock","published_at":"2026-07-23T20:09:01.000Z","date":"2026-07-21","kind":"exercise","planned":true,"acquired":true,"shares":3500,"price":7.8,"value":27300.0,"ownership":{"direct":true},"balance_after":157402,"source":{"system":"sec-edgar","filing":"0001061983-26-000084","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198326000084/form4.xml","form_type":"4"}},{"id":708347,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":16754,"kind":"person","name":"Wysenski Nancy","position":1,"cik":"0001294596","reported_name":"Wysenski Nancy","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-07-16T20:35:53.000Z","date":"2026-07-15","kind":"grant","planned":false,"acquired":true,"shares":75,"price":82.62,"value":6196.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares of common stock granted pursuant to the Cytokinetics Equity in lieu of Cash Retainer Program. Shares are fully vested at the time of grant."}],"balance_after":33992,"source":{"system":"sec-edgar","filing":"0001061983-26-000083","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198326000083/form4.xml","form_type":"4"}},{"id":708351,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":17937,"kind":"person","name":"WIERENGA WENDELL","position":1,"cik":"0001239956","reported_name":"WIERENGA WENDELL","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-07-16T20:34:25.000Z","date":"2026-07-15","kind":"grant","planned":false,"acquired":true,"shares":75,"price":82.62,"value":6196.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares of common stock granted pursuant to the Cytokinetics Equity in lieu of Cash Retainer Program. Shares are fully vested at the time of grant."}],"balance_after":35563,"source":{"system":"sec-edgar","filing":"0001061983-26-000082","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198326000082/form4.xml","form_type":"4"}},{"id":708346,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":22218,"kind":"person","name":"Kaye Edward M. MD","position":1,"cik":"0001522780","reported_name":"Kaye Edward M. MD","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-07-16T20:32:49.000Z","date":"2026-07-15","kind":"grant","planned":false,"acquired":true,"shares":151,"price":82.62,"value":12475.62,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares of common stock granted pursuant to the Cytokinetics Equity in lieu of Cash Retainer Program. Shares are fully vested at the time of grant."}],"balance_after":10434,"source":{"system":"sec-edgar","filing":"0001061983-26-000081","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198326000081/form4.xml","form_type":"4"}},{"id":708345,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":30156,"kind":"person","name":"HENDERSON JOHN T","position":1,"cik":"0001226488","reported_name":"HENDERSON JOHN T","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-07-16T20:31:12.000Z","date":"2026-07-15","kind":"grant","planned":false,"acquired":true,"shares":272,"price":82.62,"value":22472.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares of common stock granted pursuant to the Cytokinetics Equity in lieu of Cash Retainer Program. Shares are fully vested at the time of grant."}],"balance_after":78360,"source":{"system":"sec-edgar","filing":"0001061983-26-000080","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198326000080/form4.xml","form_type":"4"}},{"id":708344,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":30155,"kind":"person","name":"Harrington Robert Arthur","position":1,"cik":"0001923988","reported_name":"Harrington Robert Arthur","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-07-16T20:29:44.000Z","date":"2026-07-15","kind":"grant","planned":false,"acquired":true,"shares":151,"price":82.62,"value":12475.62,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares of common stock granted pursuant to the Cytokinetics Equity in lieu of Cash Retainer Program. Shares are fully vested at the time of grant."}],"balance_after":21932,"source":{"system":"sec-edgar","filing":"0001061983-26-000079","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198326000079/form4.xml","form_type":"4"}},{"id":708343,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":30154,"kind":"person","name":"Daly James M","position":1,"cik":"0001560782","reported_name":"Daly James M","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-07-16T20:28:34.000Z","date":"2026-07-15","kind":"grant","planned":false,"acquired":true,"shares":151,"price":82.62,"value":12475.62,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares of common stock granted pursuant to the Cytokinetics Equity in lieu of Cash Retainer Program. Shares are fully vested at the time of grant."}],"balance_after":3390,"source":{"system":"sec-edgar","filing":"0001061983-26-000078","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198326000078/form4.xml","form_type":"4"}},{"id":710049,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18476,"kind":"person","name":"Blum Robert I","position":1,"cik":"0001288859","reported_name":"Blum Robert I","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2026-07-14T19:34:25.000Z","date":"2026-07-13","kind":"exercise","planned":true,"acquired":false,"shares":7490,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":186745,"derivative":{"exercise_price":10.6,"exercise_date":"2017-03-28","expiration_date":"2027-02-28","underlying":"Common Stock","underlying_shares":7490},"source":{"system":"sec-edgar","filing":"0001061983-26-000077","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198326000077/form4.xml","form_type":"4"}},{"id":710048,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18476,"kind":"person","name":"Blum Robert I","position":1,"cik":"0001288859","reported_name":"Blum Robert I","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2026-07-14T19:34:25.000Z","date":"2026-07-13","kind":"sale","planned":true,"acquired":false,"shares":7490,"price":82.02,"value":614329.8,"ownership":{"direct":true},"balance_after":377820,"source":{"system":"sec-edgar","filing":"0001061983-26-000077","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198326000077/form4.xml","form_type":"4"}},{"id":710047,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18476,"kind":"person","name":"Blum Robert I","position":1,"cik":"0001288859","reported_name":"Blum Robert I","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2026-07-14T19:34:25.000Z","date":"2026-07-13","kind":"exercise","planned":true,"acquired":true,"shares":7490,"price":10.6,"value":79394.0,"ownership":{"direct":true},"balance_after":385310,"source":{"system":"sec-edgar","filing":"0001061983-26-000077","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198326000077/form4.xml","form_type":"4"}},{"id":710046,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18476,"kind":"person","name":"Blum Robert I","position":1,"cik":"0001288859","reported_name":"Blum Robert I","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2026-07-14T19:34:25.000Z","date":"2026-07-13","kind":"sale","planned":true,"acquired":false,"shares":10,"price":82.02,"value":820.2,"ownership":{"direct":true},"balance_after":377820,"source":{"system":"sec-edgar","filing":"0001061983-26-000077","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198326000077/form4.xml","form_type":"4"}},{"id":713924,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":22443,"kind":"person","name":"Malik Fady Ibraham","position":1,"cik":"0001551778","reported_name":"Malik Fady Ibraham","relationship":{"officer":true,"officer_title":"EVP Research & Development"}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2026-07-07T21:06:26.000Z","date":"2026-07-07","kind":"exercise","planned":true,"acquired":false,"shares":3500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":37386,"derivative":{"exercise_price":7.8,"exercise_date":"2018-03-27","expiration_date":"2028-02-27","underlying":"Common Stock","underlying_shares":3500},"source":{"system":"sec-edgar","filing":"0001061983-26-000075","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198326000075/form4.xml","form_type":"4"}},{"id":713923,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":22443,"kind":"person","name":"Malik Fady Ibraham","position":1,"cik":"0001551778","reported_name":"Malik Fady Ibraham","relationship":{"officer":true,"officer_title":"EVP Research & Development"}}],"security":"Common Stock","published_at":"2026-07-07T21:06:26.000Z","date":"2026-07-07","kind":"sale","planned":true,"acquired":false,"shares":3500,"price":86.62,"value":303170.0,"ownership":{"direct":true},"balance_after":153902,"source":{"system":"sec-edgar","filing":"0001061983-26-000075","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198326000075/form4.xml","form_type":"4"}},{"id":713922,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":22443,"kind":"person","name":"Malik Fady Ibraham","position":1,"cik":"0001551778","reported_name":"Malik Fady Ibraham","relationship":{"officer":true,"officer_title":"EVP Research & Development"}}],"security":"Common Stock","published_at":"2026-07-07T21:06:26.000Z","date":"2026-07-07","kind":"exercise","planned":true,"acquired":true,"shares":3500,"price":7.8,"value":27300.0,"ownership":{"direct":true},"balance_after":157402,"source":{"system":"sec-edgar","filing":"0001061983-26-000075","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198326000075/form4.xml","form_type":"4"}},{"id":719053,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18476,"kind":"person","name":"Blum Robert I","position":1,"cik":"0001288859","reported_name":"Blum Robert I","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2026-07-02T21:20:26.000Z","date":"2026-07-01","kind":"sale","planned":true,"acquired":false,"shares":7500,"price":84.92,"value":636900.0,"ownership":{"direct":true},"balance_after":377830,"source":{"system":"sec-edgar","filing":"0001061983-26-000074","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198326000074/form4.xml","form_type":"4"}},{"id":719052,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18477,"kind":"person","name":"Callos Andrew","position":1,"cik":"0001852129","reported_name":"Callos Andrew","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2026-07-02T21:19:20.000Z","date":"2026-07-01","kind":"exercise","planned":true,"acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock options will vest over 4 years from the date of the grant, with 1/4th of the shares underlying the reporting person's option vesting on the one-year anniversary of the grant date and the remaining shares thereafter vesting monthly at a rate of 1/48th of the shares underlying the reporting person's option over the subsequent 36 months, subject to the reporting person's continued employment with the Issuer."}],"balance_after":24000,"derivative":{"exercise_price":23.26,"exercise_date":"2022-03-31","expiration_date":"2031-03-31","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001061983-26-000073","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198326000073/form4.xml","form_type":"4"}},{"id":719051,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18477,"kind":"person","name":"Callos Andrew","position":1,"cik":"0001852129","reported_name":"Callos Andrew","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-07-02T21:19:20.000Z","date":"2026-07-01","kind":"sale","planned":true,"acquired":false,"shares":15000,"price":85.8,"value":1287000.0,"ownership":{"direct":true},"balance_after":58555,"source":{"system":"sec-edgar","filing":"0001061983-26-000073","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198326000073/form4.xml","form_type":"4"}},{"id":719050,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18477,"kind":"person","name":"Callos Andrew","position":1,"cik":"0001852129","reported_name":"Callos Andrew","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-07-02T21:19:20.000Z","date":"2026-07-01","kind":"exercise","planned":true,"acquired":true,"shares":15000,"price":23.26,"value":348900.0,"ownership":{"direct":true},"balance_after":73555,"source":{"system":"sec-edgar","filing":"0001061983-26-000073","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198326000073/form4.xml","form_type":"4"}},{"id":719930,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":33455,"kind":"person","name":"Lee Sung","position":1,"cik":"0001793200","reported_name":"Lee Sung","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2026-07-02T21:17:53.000Z","date":"2026-07-01","kind":"exercise","planned":true,"acquired":false,"shares":1112,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":26709,"derivative":{"exercise_price":48.51,"exercise_date":"2025-06-02","expiration_date":"2034-05-30","underlying":"Common Stock","underlying_shares":1112},"source":{"system":"sec-edgar","filing":"0001061983-26-000072","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1793200/000106198326000072/form4.xml","form_type":"4"}},{"id":719929,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":33455,"kind":"person","name":"Lee Sung","position":1,"cik":"0001793200","reported_name":"Lee Sung","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-07-02T21:17:53.000Z","date":"2026-07-01","kind":"sale","planned":true,"acquired":false,"shares":1112,"price":87.79,"value":97622.48,"ownership":{"direct":true},"balance_after":63221,"source":{"system":"sec-edgar","filing":"0001061983-26-000072","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1793200/000106198326000072/form4.xml","form_type":"4"}},{"id":719928,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":33455,"kind":"person","name":"Lee Sung","position":1,"cik":"0001793200","reported_name":"Lee Sung","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-07-02T21:17:53.000Z","date":"2026-07-01","kind":"exercise","planned":true,"acquired":true,"shares":1112,"price":48.51,"value":53943.12,"ownership":{"direct":true},"balance_after":64333,"source":{"system":"sec-edgar","filing":"0001061983-26-000072","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1793200/000106198326000072/form4.xml","form_type":"4"}},{"id":724896,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":33455,"kind":"person","name":"Lee Sung","position":1,"cik":"0001793200","reported_name":"Lee Sung","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2026-06-29T22:05:24.000Z","date":"2026-06-24","kind":"exercise","planned":true,"acquired":false,"shares":1113,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":27821,"derivative":{"exercise_price":48.51,"exercise_date":"2025-06-02","expiration_date":"2034-05-30","underlying":"Common Stock","underlying_shares":1113},"source":{"system":"sec-edgar","filing":"0001061983-26-000071","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1793200/000106198326000071/form4.xml","form_type":"4"}},{"id":724895,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":33455,"kind":"person","name":"Lee Sung","position":1,"cik":"0001793200","reported_name":"Lee Sung","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2026-06-29T22:05:24.000Z","date":"2026-06-24","kind":"exercise","planned":true,"acquired":false,"shares":822,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":31197,"derivative":{"exercise_price":44.36,"exercise_date":"2025-04-14","expiration_date":"2035-03-13","underlying":"Common Stock","underlying_shares":822},"source":{"system":"sec-edgar","filing":"0001061983-26-000071","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1793200/000106198326000071/form4.xml","form_type":"4"}},{"id":724894,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":33455,"kind":"person","name":"Lee Sung","position":1,"cik":"0001793200","reported_name":"Lee Sung","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Incentive Stock Option (Right to Buy)","published_at":"2026-06-29T22:05:24.000Z","date":"2026-06-24","kind":"exercise","planned":true,"acquired":false,"shares":188,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":6011,"derivative":{"exercise_price":44.36,"exercise_date":"2025-04-14","expiration_date":"2035-03-13","underlying":"Common Stock","underlying_shares":188},"source":{"system":"sec-edgar","filing":"0001061983-26-000071","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1793200/000106198326000071/form4.xml","form_type":"4"}},{"id":724893,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":33455,"kind":"person","name":"Lee Sung","position":1,"cik":"0001793200","reported_name":"Lee Sung","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2026-06-29T22:05:24.000Z","date":"2026-06-24","kind":"exercise","planned":true,"acquired":false,"shares":1113,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":28934,"derivative":{"exercise_price":48.51,"exercise_date":"2025-06-02","expiration_date":"2034-05-30","underlying":"Common Stock","underlying_shares":1113},"source":{"system":"sec-edgar","filing":"0001061983-26-000071","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1793200/000106198326000071/form4.xml","form_type":"4"}},{"id":724892,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":33455,"kind":"person","name":"Lee Sung","position":1,"cik":"0001793200","reported_name":"Lee Sung","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Incentive Stock Option (Right to Buy)","published_at":"2026-06-29T22:05:24.000Z","date":"2026-06-24","kind":"exercise","planned":true,"acquired":false,"shares":2817,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":6199,"derivative":{"exercise_price":44.36,"exercise_date":"2025-04-14","expiration_date":"2035-03-13","underlying":"Common Stock","underlying_shares":2817},"source":{"system":"sec-edgar","filing":"0001061983-26-000071","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1793200/000106198326000071/form4.xml","form_type":"4"}},{"id":724891,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":33455,"kind":"person","name":"Lee Sung","position":1,"cik":"0001793200","reported_name":"Lee Sung","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2026-06-29T22:05:24.000Z","date":"2026-06-24","kind":"exercise","planned":true,"acquired":false,"shares":9307,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":32019,"derivative":{"exercise_price":44.36,"exercise_date":"2025-04-14","expiration_date":"2035-03-13","underlying":"Common Stock","underlying_shares":9307},"source":{"system":"sec-edgar","filing":"0001061983-26-000071","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1793200/000106198326000071/form4.xml","form_type":"4"}},{"id":724890,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":33455,"kind":"person","name":"Lee Sung","position":1,"cik":"0001793200","reported_name":"Lee Sung","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2026-06-29T22:05:24.000Z","date":"2026-06-24","kind":"exercise","planned":true,"acquired":false,"shares":23370,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":30047,"derivative":{"exercise_price":48.51,"exercise_date":"2025-06-02","expiration_date":"2034-05-30","underlying":"Common Stock","underlying_shares":23370},"source":{"system":"sec-edgar","filing":"0001061983-26-000071","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1793200/000106198326000071/form4.xml","form_type":"4"}},{"id":724889,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":33455,"kind":"person","name":"Lee Sung","position":1,"cik":"0001793200","reported_name":"Lee Sung","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-29T22:05:24.000Z","date":"2026-06-24","kind":"sale","planned":true,"acquired":false,"shares":38730,"price":82.3,"value":3187479.0,"ownership":{"direct":true},"balance_after":63221,"source":{"system":"sec-edgar","filing":"0001061983-26-000071","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1793200/000106198326000071/form4.xml","form_type":"4"}},{"id":724888,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":33455,"kind":"person","name":"Lee Sung","position":1,"cik":"0001793200","reported_name":"Lee Sung","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-29T22:05:24.000Z","date":"2026-06-24","kind":"exercise","planned":true,"acquired":true,"shares":1113,"price":48.51,"value":53991.63,"ownership":{"direct":true},"balance_after":101951,"source":{"system":"sec-edgar","filing":"0001061983-26-000071","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1793200/000106198326000071/form4.xml","form_type":"4"}},{"id":724887,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":33455,"kind":"person","name":"Lee Sung","position":1,"cik":"0001793200","reported_name":"Lee Sung","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-29T22:05:24.000Z","date":"2026-06-24","kind":"exercise","planned":true,"acquired":true,"shares":822,"price":44.36,"value":36463.92,"ownership":{"direct":true},"balance_after":100838,"source":{"system":"sec-edgar","filing":"0001061983-26-000071","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1793200/000106198326000071/form4.xml","form_type":"4"}},{"id":724886,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":33455,"kind":"person","name":"Lee Sung","position":1,"cik":"0001793200","reported_name":"Lee Sung","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-29T22:05:24.000Z","date":"2026-06-24","kind":"exercise","planned":true,"acquired":true,"shares":188,"price":44.36,"value":8339.68,"ownership":{"direct":true},"balance_after":100016,"source":{"system":"sec-edgar","filing":"0001061983-26-000071","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1793200/000106198326000071/form4.xml","form_type":"4"}},{"id":724885,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":33455,"kind":"person","name":"Lee Sung","position":1,"cik":"0001793200","reported_name":"Lee Sung","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-29T22:05:24.000Z","date":"2026-06-24","kind":"exercise","planned":true,"acquired":true,"shares":1113,"price":48.51,"value":53991.63,"ownership":{"direct":true},"balance_after":99828,"source":{"system":"sec-edgar","filing":"0001061983-26-000071","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1793200/000106198326000071/form4.xml","form_type":"4"}},{"id":724884,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":33455,"kind":"person","name":"Lee Sung","position":1,"cik":"0001793200","reported_name":"Lee Sung","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-29T22:05:24.000Z","date":"2026-06-24","kind":"exercise","planned":true,"acquired":true,"shares":2817,"price":44.36,"value":124962.12,"ownership":{"direct":true},"balance_after":98715,"source":{"system":"sec-edgar","filing":"0001061983-26-000071","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1793200/000106198326000071/form4.xml","form_type":"4"}},{"id":724883,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":33455,"kind":"person","name":"Lee Sung","position":1,"cik":"0001793200","reported_name":"Lee Sung","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-29T22:05:24.000Z","date":"2026-06-24","kind":"exercise","planned":true,"acquired":true,"shares":9307,"price":44.36,"value":412858.52,"ownership":{"direct":true},"balance_after":95898,"source":{"system":"sec-edgar","filing":"0001061983-26-000071","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1793200/000106198326000071/form4.xml","form_type":"4"}},{"id":724882,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":33455,"kind":"person","name":"Lee Sung","position":1,"cik":"0001793200","reported_name":"Lee Sung","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-29T22:05:24.000Z","date":"2026-06-24","kind":"exercise","planned":true,"acquired":true,"shares":23370,"price":48.51,"value":1133678.7,"ownership":{"direct":true},"balance_after":86591,"source":{"system":"sec-edgar","filing":"0001061983-26-000071","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1793200/000106198326000071/form4.xml","form_type":"4"}},{"id":724881,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":33455,"kind":"person","name":"Lee Sung","position":1,"cik":"0001793200","reported_name":"Lee Sung","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2026-06-29T21:23:39.000Z","date":"2026-06-29","kind":"exercise","planned":true,"acquired":false,"shares":823,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":39681,"derivative":{"exercise_price":44.36,"exercise_date":"2025-04-14","expiration_date":"2035-03-13","underlying":"Common Stock","underlying_shares":823},"source":{"system":"sec-edgar","filing":"0001061983-26-000070","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1793200/000106198326000070/form4.xml","form_type":"4"}},{"id":724880,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":33455,"kind":"person","name":"Lee Sung","position":1,"cik":"0001793200","reported_name":"Lee Sung","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Incentive Stock Option (Right to Buy)","published_at":"2026-06-29T21:23:39.000Z","date":"2026-06-29","kind":"exercise","planned":true,"acquired":false,"shares":188,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":8640,"derivative":{"exercise_price":44.36,"exercise_date":"2025-04-14","expiration_date":"2035-03-13","underlying":"Common Stock","underlying_shares":188},"source":{"system":"sec-edgar","filing":"0001061983-26-000070","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1793200/000106198326000070/form4.xml","form_type":"4"}},{"id":724879,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":33455,"kind":"person","name":"Lee Sung","position":1,"cik":"0001793200","reported_name":"Lee Sung","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2026-06-29T21:23:39.000Z","date":"2026-06-29","kind":"exercise","planned":true,"acquired":false,"shares":1113,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":52304,"derivative":{"exercise_price":48.51,"exercise_date":"2025-06-02","expiration_date":"2034-05-30","underlying":"Common Stock","underlying_shares":1113},"source":{"system":"sec-edgar","filing":"0001061983-26-000070","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1793200/000106198326000070/form4.xml","form_type":"4"}},{"id":724878,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":33455,"kind":"person","name":"Lee Sung","position":1,"cik":"0001793200","reported_name":"Lee Sung","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2026-06-29T21:23:39.000Z","date":"2026-06-29","kind":"exercise","planned":true,"acquired":false,"shares":822,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":40504,"derivative":{"exercise_price":44.36,"exercise_date":"2025-04-14","expiration_date":"2035-03-13","underlying":"Common Stock","underlying_shares":822},"source":{"system":"sec-edgar","filing":"0001061983-26-000070","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1793200/000106198326000070/form4.xml","form_type":"4"}},{"id":724877,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":33455,"kind":"person","name":"Lee Sung","position":1,"cik":"0001793200","reported_name":"Lee Sung","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Incentive Stock Option (Right to Buy)","published_at":"2026-06-29T21:23:39.000Z","date":"2026-06-29","kind":"exercise","planned":true,"acquired":false,"shares":188,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":8828,"derivative":{"exercise_price":44.36,"exercise_date":"2025-04-14","expiration_date":"2035-03-13","underlying":"Common Stock","underlying_shares":188},"source":{"system":"sec-edgar","filing":"0001061983-26-000070","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1793200/000106198326000070/form4.xml","form_type":"4"}},{"id":724876,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":33455,"kind":"person","name":"Lee Sung","position":1,"cik":"0001793200","reported_name":"Lee Sung","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-29T21:23:39.000Z","date":"2026-06-29","kind":"sale","planned":true,"acquired":false,"shares":3134,"price":85,"value":266390.0,"ownership":{"direct":true},"balance_after":63221,"source":{"system":"sec-edgar","filing":"0001061983-26-000070","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1793200/000106198326000070/form4.xml","form_type":"4"}},{"id":724875,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":33455,"kind":"person","name":"Lee Sung","position":1,"cik":"0001793200","reported_name":"Lee Sung","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-29T21:23:39.000Z","date":"2026-06-29","kind":"exercise","planned":true,"acquired":true,"shares":823,"price":44.36,"value":36508.28,"ownership":{"direct":true},"balance_after":66355,"source":{"system":"sec-edgar","filing":"0001061983-26-000070","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1793200/000106198326000070/form4.xml","form_type":"4"}},{"id":724874,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":33455,"kind":"person","name":"Lee Sung","position":1,"cik":"0001793200","reported_name":"Lee Sung","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-29T21:23:39.000Z","date":"2026-06-29","kind":"exercise","planned":true,"acquired":true,"shares":188,"price":44.36,"value":8339.68,"ownership":{"direct":true},"balance_after":65532,"source":{"system":"sec-edgar","filing":"0001061983-26-000070","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1793200/000106198326000070/form4.xml","form_type":"4"}},{"id":724873,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":33455,"kind":"person","name":"Lee Sung","position":1,"cik":"0001793200","reported_name":"Lee Sung","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-29T21:23:39.000Z","date":"2026-06-29","kind":"exercise","planned":true,"acquired":true,"shares":1113,"price":48.51,"value":53991.63,"ownership":{"direct":true},"balance_after":65344,"source":{"system":"sec-edgar","filing":"0001061983-26-000070","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1793200/000106198326000070/form4.xml","form_type":"4"}},{"id":724872,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":33455,"kind":"person","name":"Lee Sung","position":1,"cik":"0001793200","reported_name":"Lee Sung","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-29T21:23:39.000Z","date":"2026-06-29","kind":"exercise","planned":true,"acquired":true,"shares":822,"price":44.36,"value":36463.92,"ownership":{"direct":true},"balance_after":64231,"source":{"system":"sec-edgar","filing":"0001061983-26-000070","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1793200/000106198326000070/form4.xml","form_type":"4"}},{"id":724871,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":33455,"kind":"person","name":"Lee Sung","position":1,"cik":"0001793200","reported_name":"Lee Sung","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-29T21:23:39.000Z","date":"2026-06-29","kind":"exercise","planned":true,"acquired":true,"shares":188,"price":44.36,"value":8339.68,"ownership":{"direct":true},"balance_after":63409,"source":{"system":"sec-edgar","filing":"0001061983-26-000070","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1793200/000106198326000070/form4.xml","form_type":"4"}},{"id":729508,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":22443,"kind":"person","name":"Malik Fady Ibraham","position":1,"cik":"0001551778","reported_name":"Malik Fady Ibraham","relationship":{"officer":true,"officer_title":"EVP Research & Development"}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2026-06-23T21:41:41.000Z","date":"2026-06-23","kind":"exercise","planned":true,"acquired":false,"shares":3500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":40886,"derivative":{"exercise_price":7.8,"exercise_date":"2018-03-27","expiration_date":"2028-02-27","underlying":"Common Stock","underlying_shares":3500},"source":{"system":"sec-edgar","filing":"0001061983-26-000069","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198326000069/form4.xml","form_type":"4"}},{"id":729507,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":22443,"kind":"person","name":"Malik Fady Ibraham","position":1,"cik":"0001551778","reported_name":"Malik Fady Ibraham","relationship":{"officer":true,"officer_title":"EVP Research & Development"}}],"security":"Common Stock","published_at":"2026-06-23T21:41:41.000Z","date":"2026-06-23","kind":"sale","planned":true,"acquired":false,"shares":3500,"price":79.51,"value":278285.0,"ownership":{"direct":true},"balance_after":153902,"source":{"system":"sec-edgar","filing":"0001061983-26-000069","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198326000069/form4.xml","form_type":"4"}},{"id":729506,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":22443,"kind":"person","name":"Malik Fady Ibraham","position":1,"cik":"0001551778","reported_name":"Malik Fady Ibraham","relationship":{"officer":true,"officer_title":"EVP Research & Development"}}],"security":"Common Stock","published_at":"2026-06-23T21:41:41.000Z","date":"2026-06-23","kind":"exercise","planned":true,"acquired":true,"shares":3500,"price":7.8,"value":27300.0,"ownership":{"direct":true},"balance_after":157402,"source":{"system":"sec-edgar","filing":"0001061983-26-000069","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198326000069/form4.xml","form_type":"4"}},{"id":738331,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18476,"kind":"person","name":"Blum Robert I","position":1,"cik":"0001288859","reported_name":"Blum Robert I","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2026-06-15T20:40:29.000Z","date":"2026-06-15","kind":"sale","planned":true,"acquired":false,"shares":7500,"price":70.46,"value":528450.0,"ownership":{"direct":true},"balance_after":385330,"source":{"system":"sec-edgar","filing":"0001061983-26-000068","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198326000068/form4.xml","form_type":"4"}},{"id":745175,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":22443,"kind":"person","name":"Malik Fady Ibraham","position":1,"cik":"0001551778","reported_name":"Malik Fady Ibraham","relationship":{"officer":true,"officer_title":"EVP Research & Development"}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2026-06-09T21:40:07.000Z","date":"2026-06-09","kind":"exercise","planned":true,"acquired":false,"shares":3500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":44386,"derivative":{"exercise_price":7.8,"exercise_date":"2018-03-27","expiration_date":"2028-02-27","underlying":"Common Stock","underlying_shares":3500},"source":{"system":"sec-edgar","filing":"0001061983-26-000067","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198326000067/form4.xml","form_type":"4"}},{"id":745174,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":22443,"kind":"person","name":"Malik Fady Ibraham","position":1,"cik":"0001551778","reported_name":"Malik Fady Ibraham","relationship":{"officer":true,"officer_title":"EVP Research & Development"}}],"security":"Common Stock","published_at":"2026-06-09T21:40:07.000Z","date":"2026-06-09","kind":"sale","planned":true,"acquired":false,"shares":3500,"price":67.98,"value":237930.0,"ownership":{"direct":true},"balance_after":153902,"source":{"system":"sec-edgar","filing":"0001061983-26-000067","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198326000067/form4.xml","form_type":"4"}},{"id":745173,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":22443,"kind":"person","name":"Malik Fady Ibraham","position":1,"cik":"0001551778","reported_name":"Malik Fady Ibraham","relationship":{"officer":true,"officer_title":"EVP Research & Development"}}],"security":"Common Stock","published_at":"2026-06-09T21:40:07.000Z","date":"2026-06-09","kind":"exercise","planned":true,"acquired":true,"shares":3500,"price":7.8,"value":27300.0,"ownership":{"direct":true},"balance_after":157402,"source":{"system":"sec-edgar","filing":"0001061983-26-000067","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198326000067/form4.xml","form_type":"4"}},{"id":757670,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":22218,"kind":"person","name":"Kaye Edward M. MD","position":1,"cik":"0001522780","reported_name":"Kaye Edward M. MD","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-06-01T22:54:01.000Z","date":"2026-06-01","kind":"sale","planned":true,"acquired":false,"shares":2933,"price":76.09,"value":223171.97,"ownership":{"direct":true},"balance_after":10283,"source":{"system":"sec-edgar","filing":"0001061983-26-000066","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198326000066/form4.xml","form_type":"4"}}],"next_cursor":"2026-06-01T22:54:01.000000Z,757670"}